Search - tctmd.com

Presenter: Yun-Kyeong Cho, Ji-Hyun Sohn, Hyun-Ok Cho, Hyoung-Seob Park, Hyuck-Jun Yoon, Hyungseop Kim, Chang-Wook Nam, Seung-Ho Hur, Yoon-Nyun Kim, Kwon-Bae Kim

January 31, 2013

News Daily News

Registry: Contralateral Occlusion Poses No Risk for Elective CAS

Caitlin E. Cox

January 24, 2013

News Daily News

Unknowns Predominate in Variable Clopidogrel Response

January 16, 2013

News Daily News

Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel

January 16, 2013

Presentation

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func

Presenter: Andrew L. Frelinger

January 15, 2013

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

Advertisement

Quitting Smoking After PCI Can Add Years to Patients’ Lives

Dejar de Fumar tras una PCI Suma Años a las Vidas de los pacientes

Life Years Gained by Smoking Cessation After PCI

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Long-term Mortality in Refractory Angina May Be Lower Than Thought

PARADOX Published: Smokers’ Paradox Seen with Clopidogrel But not Prasugrel

PARADOX Publicado: La Paradoja del Fumador se observa con el Clopidogrel pero No con el Prasugrel

Obesity Paradox Revisited: Lower BMI Linked to Higher Death, CV Events After PCI

PARADOX: Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

Sedation Plus Analgesia Improves Transradial PCI by Decreasing Spasm

Younger Women Fare Worse Than Men After PCI for STEMI

CTA Charts Prognosis Even in Stable Patients Without Typical Risk Factors

Impact of Smoking on Outcomes of Acute Myocardial Infarction After Drug-Eluting Stent Implantation: The Smoker’s Paradox

Registry: Contralateral Occlusion Poses No Risk for Elective CAS

Unknowns Predominate in Variable Clopidogrel Response

Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content